Skip to content

PLURIPHARM BELGIUM

Active Private limited companyfounded 2024active for 2 yearsOudebaan 61, 2610 AntwerpKBO/BCE: BE 1011.718.215 subsidiary of

Board

2 directors, no change since December 2024
Director
appointed by deed of 04-03-2025 term without a fixed end
Director
appointed by deed of 04-03-2025 term without a fixed end
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Iedere bestuurder afzonderlijk, ook wanneer er meerdere zijn, vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als…”
deed of 22-07-2024

Office holders in the KBO →

Mandates through the years

4 names, the dashed line is today

Director

Director

Director

Director
BoardEarlier
Mandates as a list
    • Director, appointed by deed of 04-03-2025, still in office
    • Director, appointed by deed of 04-03-2025, still in office
    • Director, appointed by deed of 22-07-2024, until 20-12-2024
    • Director, appointed by deed of 22-07-2024, until 20-12-2024

Control

Parent
Equity €1.4m
Profit €38,544 in 2025 (profit €316,411 in 2024)
Checked score
Source: accounts 2024
100%
This company
PLURIPHARM BELGIUM
Equity €5,000

Capital

Contribution
€5,000
Shares
100
Contribution per share
€50
Equity per share
€50 in 2024
Source
deed of 22-07-2024

Articles of association

deed of 22-07-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“TITEL V. ALGEMENE VERGADERING Artikel 16. Datum algemene vergadering - Organisatie en bijeenroeping Ieder jaar wordt een gewone algemene…”

Capital transactions

Shareholders according to the deeds
At incorporation deed of 22-07-2024 ↗
  • 100 shares (100%) · in cash
Capital over time
  1. 22-07-2024 Incorporation · €5,000 · 100 shares

Next steps